Article citationsMore>>

Lacey, J.V., Mutter, G.L., Ronnett, B.M., Ioffe, O.B., Duggan, M.A., Rush, B.B., et al. (2008) PTEN Expression in Endometrial Biopsies as a Marker of Progression to Endometrial Carcinoma. Cancer Research, 68, 6014-6020.
https://doi.org/10.1158/0008-5472.can-08-1154

has been cited by the following article:

• TITLE: Endometrial Hyperplasia with Conservative Treatment Using the Progestin or EP Agents, Compared to Cases that Worsen during Observation

  AUTHORS: Kenji Niwa, Saki Tsurue, Kentaro Niwa, Yoh Hayasaki, Masanori Isobe, Takuji Tanaka

  KEYWORDS: Endometrial Hyperplasia, Progestin, EP, PTEN-Null

  JOURNAL NAME: Open Journal of Pathology, Vol.16 No.1, January 4, 2026

  ABSTRACT: A total of 157 patients were included in this study, comprising 147 with simple Endometrial Hyperplasia (EH) and 10 with complex EH. All patients treated cyclically with progestin or Estrogen-Progestin (EP) exhibited regression of EH after 3 or 4 treatment courses. The relapse rate in patients treated cyclically with progestin was significantly lower than that in those treated with EP for simple EH (P